Meike Vogler

Goethe University Frankfurt

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Jo Caers

BELGIUM

View details

Martin Suchan

Head of PCR Analytics

GERMANY

View details

Thomas Bukur

GERMANY

View details

Supriya Chakraborty

Research Assistant Professor

Levine Cancer Institute

UNITED STATES

View details

Victoria M Smith

University of Southampton

UNITED KINGDOM

View details

Gregory Ehx

University of Liege

BELGIUM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Meike Vogler

Research Interests

Explore related searches

Contact this professor

Articles (10)

Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids

Unleashing the power of NK cells in anticancer immunotherapy

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology & Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)

It's time to die: BH3 mimetics in solid tumors

BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.

A direct comparison of selective BH3-mimetics reveals BCL-X<inf>L</inf>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma

Dlbcl cells with acquired resistance to venetoclax are not sensitized to bird-2 but can be resensitized to venetoclax through BCL-XL inhibition

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways

Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis

Collaborators (6)

Jo Caers

Martin Suchan

Thomas Bukur

Supriya Chakraborty

Victoria M Smith

Gregory Ehx

Make your next move.

Meike Vogler

Research Interests

Explore related searches

Contact this professor

Articles (10)

Characterization of BV6-Induced Sensitization to the NK Cell Killing of Pediatric Rhabdomyosarcoma Spheroids

Unleashing the power of NK cells in anticancer immunotherapy

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology &amp; Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)

It's time to die: BH3 mimetics in solid tumors

BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models.

A direct comparison of selective BH3-mimetics reveals BCL-X<inf>L</inf>, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma

Dlbcl cells with acquired resistance to venetoclax are not sensitized to bird-2 but can be resensitized to venetoclax through BCL-XL inhibition

MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents

Next-generation hypomethylating agent SGI-110 primes acute myeloid leukemia cells to IAP antagonist by activating extrinsic and intrinsic apoptosis pathways

Proteasome inhibitors and Smac mimetics cooperate to induce cell death in diffuse large B-cell lymphoma by stabilizing NOXA and triggering mitochondrial apoptosis

Collaborators (6)

Jo Caers

Martin Suchan

Thomas Bukur

Supriya Chakraborty

Victoria M Smith

Gregory Ehx

Make your next move.

Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents (Journal of Hematology & Oncology, (2020), 13, 1, (173), 10.1186/s13045-020-01007-9)